The last several years have seen increasing interest in understanding cachexia, muscle
wasting, and physical frailty across the broad spectrum of patients with cardiovascular …

Cachexia is a severe complication of cancer that adversely affects the course of the disease,
with currently no effective treatments. It is characterized by a progressive atrophy of skeletal …

Research about heart failure (HF) has made major progress in the last years. We give here
an update on the most recent findings. Landmark trials have established new treatments for …

At least half of all patients with heart failure (HF) are affected by frailty, a syndrome that limits
an individual ability to recover from acute stressors. While frailty affects up to 90% of patients …

Skeletal muscle, which accounts for approximately 40% of total body weight, is one of the
most dynamic and plastic tissues in the human body and plays a vital role in movement …

Low muscle mass and function exert a substantial negative impact on quality of life, health
and ultimately survival, but their definition, identification and combination to define …

Background: A strategy to predict mortality in elderly heart failure (HF) patients has not been
established. Methods and Results: We retrospectively enrolled 413 HF patients aged≥ 65 …

Computed tomography (CT) is a valuable assessment method for muscle pathologies such
as sarcopenia, cachexia, and myosteatosis. However, several key underappreciated scan …

Major changes have occurred in these last years in heart failure (HF) management.
Landmark trials and the 2021 European Society of Cardiology guidelines for the diagnosis …

Abstract Purpose of Review Sarcopenia and frailty are common in patients with heart failure
(HF) and are strongly associated with prognosis. This review aims to examine promising …